The Archimedes Biodegradable Biliary and Pancreatic Stents
Completed
- Conditions
- Pancreatic Diseases
- Registration Number
- NCT03767166
- Lead Sponsor
- Istituto Clinico Humanitas
- Brief Summary
This is a prospective, phase II, single-centre, non-randomised, single-arm study, enrolling patients with benign and malignant bilio-pancreatic diseases with an indication to biliary or pancreatic plastic stent positioning during ERCP.
On procedure day, the study team will confirm that the patient meets all the inclusion criteria and none of the exclusion criteria.
The patient will undergo the ABS insertion and monitored and follow-up accordingly to biodegration variant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients with an indication to position one ore more biliary plastic stents during ERCP
- Patients with an indication to position a pancreatic plastic stent during ERCP
Exclusion Criteria
- Age < 18 y
- Life expectancy < 1 m,
- Inability to pass a guidewire through stricture
- Contra-indication for endoscopy or interventional radiology
- Presence of partial gastric resection
- Unsigned informing consent form, ICF
- Pregnancy
- Pseudo Klatskin tumors (metastases in the liver hilum) and gallbladder carcinoma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biodegradation time 24 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Endoscopy Unit, Humanitas Research Hospital
🇮🇹Rozzano, Milano, Italy
Endoscopy Unit, Humanitas Research Hospital🇮🇹Rozzano, Milano, Italy